Anixa Biosciences
ANIX
15 hedge funds and large institutions have $404K invested in Anixa Biosciences in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
20% more capital invested
Capital invested by funds: $337K → $404K (+$66.9K)
0% more funds holding
Funds holding: 15 → 15 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$487 |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$390 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$35K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$14.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8.96K |
| 4 |
Morgan Stanley
New York
|
-$52 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BA
1
Bard Associates
Chicago,
Illinois
| $176K | -$14.6K | -4,800 | -8% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $107K | – | – | – |
|
|
DIA
3
Denver Investment Advisors
Denver,
Colorado
| $58K | – | – | – |
|
|
4
Morgan Stanley
New York
| $31K | -$52 | -17 | -0.2% |
|
5
First Manhattan
New York
| $8K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $7K | -$8.96K | -2,941 | -57% |
|
|
BFA
7
BlackRock Fund Advisors
San Francisco,
California
| $5K | +$390 | +128 | +10% |
|
|
JCM
8
Jacobi Capital Management
Pittston,
Pennsylvania
| $4K | +$4.02K | +1,320 | New |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $3K | +$487 | +160 | +20% |
|
10
Wells Fargo
San Francisco,
California
| $2K | – | – | – |
|
|
EWM
11
Evercore Wealth Management
New York
| $1K | – | – | – |
|
|
MFW
12
Mosaic Family Wealth
St. Louis,
Missouri
| $1K | – | – | – |
|
|
13
Bank of America
Charlotte,
North Carolina
| $1K | +$9 | +3 | +0.8% |
|
|
14
Millennium Management
New York
| – | -$35K | -11,481 | Closed |
|
ANIX Hedge Fund Activity: Q2 2016 in Review
15 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Anixa Biosciences (ANIX) for Q2 2016, worth a combined $404K — up 20% from $337K a quarter earlier.
Fund positioning in ANIX was balanced in Q2 2016: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $487. The largest seller was Millennium Management, exiting entirely with an estimated $35K sold.
- 15 institutional investors held Anixa Biosciences (ANIX) as of Q2 2016, unchanged from Q1 2016.
- Funds reported $404K of Anixa Biosciences stock for Q2 2016, up 20% quarter-over-quarter.
- 1 fund opened new Anixa Biosciences positions in Q2 2016 and 1 closed out, a net change of 0 holders.
- The largest Anixa Biosciences buyer in Q2 2016 was Tower Research Capital (TRC), an estimated $487 added.
- The largest Anixa Biosciences seller in Q2 2016 was Millennium Management, an estimated $35K sold.
Based on aggregated 13F filings for Q2 2016.